Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 3/20 | 0.42 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | DUT | P33316 | 2/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | GSK3B | P49841 | 1/20 | 0.32 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.32 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.32 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.32 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20365469 | 0.82 | CRBN (0.44) | CRBNDDB1ALDH1A1LMNADUT | |
| SCHEMBL10953746 | 0.78 | CRBN (0.50) | CRBNDDB1ALDH1A1LMNADUT | |
| SCHEMBL27581645 | 0.78 | CRBN (0.50) | CRBNDDB1ALDH1A1LMNADUT | |
| SCHEMBL2976955 | 0.76 | CRBN (0.48) | CRBNDDB1ALDH1A1LMNADUT | |
| SCHEMBL7056290 | 0.75 | CRBN (0.52) | CRBNDDB1ALDH1A1LMNADUT | |
| SCHEMBL4755093 | 0.75 | CRBN (0.52) | CRBNDDB1ALDH1A1LMNADUT | |
| SCHEMBL28132697 | 0.75 | CRBN (0.47) | CRBNDDB1ALDH1A1LMNADUT | |
| SCHEMBL1526612 | 0.74 | CRBN (0.47) | CRBNDDB1ALDH1A1LMNADUT | |
| SCHEMBL7559284 | 0.74 | CYP3A4 (0.39) | CRBNALDH1A1LMNADUTPKM | |
| SCHEMBL24755086 | 0.73 | CRBN (0.50) | CRBNDDB1ALDH1A1LMNADUT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113413483-B | Adhesive-non-adhesive integrated hydrogel, preparation method thereof and application thereof in wound repair | 四川大学 | 2022-07-05 | — | — | CN | claimed |
| CN-113413483-A | Adhesive-non-adhesive integrated hydrogel, preparation method thereof and application thereof in wound repair | 四川大学 | 2021-09-21 | — | — | CN | claimed |
| EP-2764065-B1 | SACRIFICIAL ADHESIVE COATINGS | ROCHAL IND LLC (US) | 2017-03-22 | — | — | EP | claimed |
| EP-2764065-A1 | SACRIFICIAL ADHESIVE COATINGS | Rochal Industries, LLP (US) | 2014-08-13 | — | — | EP | claimed |
| WO-2013052276-A1 | SACRIFICIAL ADHESIVE COATINGS | ROCHAL INDUSTRIES, LLP (US) | 2013-04-11 | — | — | WO | claimed |
| US-8263720-B1 | Sacrificial adhesive coatings | ROCHAL INDUSTRIES, LLP (US) | 2012-09-11 | — | — | US | claimed |
| US-11839626-B2 | Composition and kits for inhibition of pathogenic microbial infection and methods of using the same | ROCHAL TECHNOLOGIES LLC (US) | 2023-12-12 | — | — | US | disclosed |
| CN-113413483-B | Adhesive-non-adhesive integrated hydrogel, preparation method thereof and application thereof in wound repair | 四川大学 | 2022-07-05 | — | — | CN | disclosed |
| CN-113413483-A | Adhesive-non-adhesive integrated hydrogel, preparation method thereof and application thereof in wound repair | 四川大学 | 2021-09-21 | — | — | CN | disclosed |
| EP-3220741-B1 | COMPOSITION AND KITS FOR INHIBITION OF PATHOGENIC MICROBIAL INFECTION AND METHODS OF USING THE SAME | ROCHAL IND LLC (US) | 2021-02-24 | — | — | EP | disclosed |
| US-20170360825-A1 | Composition and Kits for Inhibition of Pathogenic Microbial Infection and Methods of Using the Same | ROCHAL INDUSTRIES, LLC (US) | 2017-12-21 | — | — | US | disclosed |
| EP-3220741-A1 | COMPOSITION AND KITS FOR INHIBITION OF PATHOGENIC MICROBIAL INFECTION AND METHODS OF USING THE SAME | Rochal Industries, LLC (US) | 2017-09-27 | — | — | EP | disclosed |
| EP-2764065-B1 | SACRIFICIAL ADHESIVE COATINGS | ROCHAL IND LLC (US) | 2017-03-22 | — | — | EP | disclosed |
| WO-2013052276-A1 | SACRIFICIAL ADHESIVE COATINGS | ROCHAL INDUSTRIES, LLP (US) | 2013-04-11 | — | — | WO | disclosed |
| US-8263720-B1 | Sacrificial adhesive coatings | ROCHAL INDUSTRIES, LLP (US) | 2012-09-11 | — | — | US | disclosed |
| EP-1968655-B1 | CONFORMABLE BANDAGE AND COATING MATERIAL | ROCHAL IND LLP (US) | 2011-03-02 | — | — | EP | disclosed |
| US-7795326-B2 | Solution of an amphiphilic copolymer of a nitrogen-containing monomer, such as N-isopropylacrylamide, and a siloxy monomer, preferably 3-(methacryloyloxy)propyltris(trimethylsiloxy)silane in non-stinging, volatile, siloxane, alkane, fluorocarbon, lor iquid or supercritical carbon dioxide; medical devices | ROCHAL INDUSTRIES, LLP (US) | 2010-09-14 | — | — | US | disclosed |
| EP-1968655-A2 | CONFORMABLE BANDAGE AND COATING MATERIAL | Rochal Industries, LLP (US) | 2008-09-17 | — | — | EP | disclosed |
| WO-2007067866-A2 | CONFORMABLE BANDAGE AND COATING MATERIAL | ROCHAL INDUSTRIES, LLP (US) | 2007-06-14 | — | — | WO | disclosed |
| US-20070129474-A1 | Solution of an amphiphilic copolymer of a nitrogen-containing monomer, such as N-isopropylacrylamide, and a siloxy monomer, preferably 3-(methacryloyloxy)propyltris(trimethylsiloxy)silane in non-stinging, volatile, siloxane, alkane, fluorocarbon, lor iquid or supercritical carbon dioxide; medical devices | ROCHAL INDUSTRIES, LLP. (US) | 2007-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170360825-A1 | Composition and Kits for Inhibition of Pathogenic Microbial Infection and Methods of Using the Same | CUTA, MMP8, MMP1 | CRBN 4054/4885DDB1 858/4885ALDH1A1 4110/4885 |
| US-11839626-B2 | Composition and kits for inhibition of pathogenic microbial infection and methods of using the same | CUTA, MMP8, MMP1 | CRBN 4054/4885DDB1 858/4885ALDH1A1 4110/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.